Skip To Main Content

Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).

Can Trulicity® (dulaglutide) be used in patients after weight loss surgeries?

Dulaglutide has not been studied in people who have undergone any type of weight loss surgery.

UK_cFAQ_GLP008_WEIGHT_LOSS_SURGERIES
UK_cFAQ_GLP008_WEIGHT_LOSS_SURGERIES
en-GB

Therapeutic Indications

Dulaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

  • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
  • in addition to other medicinal products for the treatment of diabetes. 1

References

1Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Date of Last Review: 28 July 2021

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

 If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request